ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH NEWLY DIAGNOSED NON-VALVULAR ATRIAL FIBRILLATION: COMPARISON OF THE HAS-BLED, ATRIA AND ORBIT BLEEDING RISK SCORES

被引:0
|
作者
Bartoli, L. [1 ]
Angeli, F. [1 ]
Donati, F. [1 ]
Paolisso, P. [1 ]
Bergamaschi, L. [1 ]
Magnani, I. [1 ]
Toniolo, S. [1 ]
D'Angelo, E. [1 ]
Saturi, G. [1 ]
Pizzi, C. [1 ]
Galie, N. [1 ]
机构
[1] DIMES Dipartimento Med Specialist Diagnost & Sper, Bologna, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C84
引用
收藏
页码:G34 / G35
页数:2
相关论文
共 50 条
  • [1] Evaluation of the HAS-BLED, ATRIA and ORBIT bleeding risk scores in newly diagnosed non-valvular atrial fibrillation
    Bergamaschi, L.
    Stefanizzi, A.
    Coriano, M.
    Paolisso, P.
    Magnani, I.
    Rinaldi, A.
    Saturi, G.
    Foa, A.
    Pomata, D.
    Cavazza, M.
    Caldarera, I.
    Pizzi, C.
    Galie, N.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2946 - 2946
  • [2] Comparison between HAS-BLED, ATRIA and ORBIT risk scores at predicting major bleeding event in a real life cohort of anticoagulated patients with non-valvular atrial fibrillation
    Riziq-Yousef Abumuaileq, R.
    Abu-Assi, E.
    Lopez-Lopez, A.
    Gonzalez-Ferreiro, R.
    Gonzalez-Melchor, L.
    Gonzalez-Salvado, V.
    Bouzas-Cruz, N.
    Fernandez-Lopez, X. A.
    Rodriguez-Manero, M.
    Pena-Gil, C.
    Sande-Martinez, L.
    Gonzalez-Juanatey, J. R.
    EUROPEAN HEART JOURNAL, 2016, 37 : 509 - 509
  • [3] Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin
    Senoo, Keitaro
    Proietti, Marco
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (06): : 600 - 607
  • [4] Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer
    Pastori, D.
    Marang, A.
    Bisson, A.
    Herbert, J.
    Lip, G. Y. H.
    Fauchier, L.
    EUROPEAN HEART JOURNAL, 2021, 42 : 438 - 438
  • [5] The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants
    Lip, Gregory Y. H.
    Skjoth, Flemming
    Nielsen, Peter Bronnum
    Kjaeldgaard, Jette Nordstrom
    Larsen, Torben Bjerregaard
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (05): : 574.e13 - 574.e27
  • [6] Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants
    Asuncion Esteve-Pastor, Maria
    Garcia-Fernandez, Amaya
    Roldan, Vanessa
    Marin, Francisco
    REVISTA ESPANOLA DE CARDIOLOGIA, 2017, 70 (02): : 132 - 133
  • [7] Comparison of thromboembolic and bleeding risk scores in direct oral anticoagulant naive patients with non-valvular atrial fibrillation
    Elvira-Ruiz, G.
    Caro-Martinez, C.
    Andreu-Cayuelas, J. M.
    Flores-Blanco, P. J.
    Albendin-Iglesias, H.
    Gomez-Molina, M.
    Lopez-Cuenca, A.
    Cambronero-Sanchez, F.
    Rodriguez-Serrano, A. I.
    Leithold, B. G.
    Sanchez-Galian, M. J.
    Guerrero-Perez, E.
    Bailen-Lorenzo, J. L.
    Valdes-Chavarri, M.
    Manzano Fernandez, S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 967 - 967
  • [8] HAS-BLED versus ATRIA at predicting the risk of major bleeding in a real world cohort of patients with non-valvular atrial fibrillation on vitamin K antagonists
    Riziq-Yousef Abumuaileq, R.
    Abu-Assi, E.
    Raposeiras-Roubin, S.
    Lopez-Lopez, A.
    Bouzas-Cruz, N.
    Castiniera-Busto, M.
    Gonzalez-Salvado, V.
    Gonzalez-Ferreiro, R.
    Pena-Gil, C.
    Gonzalez-Juanatey, J. R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 746 - 746
  • [9] Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a "Real-World" Population With Atrial Fibrillation Receiving Anticoagulant Therapy
    Roldan, Vanessa
    Marin, Francisco
    Fernandez, Hermogenes
    Manzano-Fernandez, Sergio
    Gallego, Pilar
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    CHEST, 2013, 143 (01) : 179 - 184
  • [10] Comparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists
    Riziq-Yousef Abumuaileq, Rami
    Abu-Assi, Emad
    Raposeiras-Roubin, Sergio
    Lopez-Lopez, Andrea
    Redondo-Dieguez, Alfredo
    Alvarez-Iglesias, Diego
    Rodriguez-Manero, Moises
    Pena-Gil, Carlos
    Ramon Gonzalez-Juanatey, Jose
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) : 1259 - 1261